How does batch traceability work in pharmaceutical warehousing?

hexxabotics · 11 Oct 2026

Batch traceability in pharmaceutical warehousing is the process of recording, linking, and maintaining the movement history of every product lot from receipt through storage, picking, and dispatch. Each batch receives a unique identifier that travels with it through every warehouse transaction, creating an unbroken chain of custody that regulators, quality teams, and supply chain managers can audit at any point.
This traceability chain matters because pharmaceutical products carry patient safety obligations that do not apply to ordinary consumer goods. A single contaminated or out-of-specification batch can affect thousands of patients, so the ability to locate, isolate, and account for every unit in that batch is a regulatory and ethical requirement rather than an optional operational feature. The sections below address the most common questions warehouse professionals ask about how pharmaceutical batch traceability actually works.

What data is captured at each stage of pharmaceutical batch tracking?

Pharmaceutical batch tracking captures a defined set of data fields at every point where a product lot changes hands, location, or status. The core data recorded includes the batch or lot number, the product identifier, the quantity, the storage location, the timestamp, and the operator or system responsible for the transaction. Expiry date and manufacturing date are captured at goods receipt and carried through all subsequent records.

At goods receipt, the warehouse records the supplier identity, purchase order reference, batch number, quantity received, manufacturing date, expiry date, and any certificate of analysis or quality release status. This is the founding entry in the batch record and must be accurate because every downstream transaction inherits from it.

During putaway and storage, the system links the batch to a specific physical location. Any subsequent location move generates a new transaction record that updates the location while preserving the batch history. Temperature excursion alerts, quarantine status changes, and quality holds are also recorded at this stage.

At picking and dispatch, the system records which batch was selected, the quantity removed, the order or destination it was allocated to, and the time of retrieval. Where First Expired First Out (FEFO) logic is applied, the system also records that the selection was made in compliance with expiry sequencing rules. The dispatch record closes the loop by linking the batch to a specific outbound shipment, customer, and delivery reference.

Together these records create a continuous audit trail. If a question arises about any unit, the warehouse can trace it from its origin batch through every location it occupied and every transaction it was part of, all the way to the customer who received it.

How does batch traceability differ from serialization in pharma?

Batch traceability tracks groups of pharmaceutical products that share the same manufacturing lot, while serialization assigns a unique identifier to every individual saleable unit. Batch traceability answers the question “where did this lot go?”, whereas serialization answers the question “where did this specific pack go?” Both are used in pharmaceutical supply chains, but they operate at different levels of granularity and serve different regulatory purposes.

Batch traceability is the older and more universal requirement. Manufacturers, wholesalers, and distributors have managed lot-level records for decades because batch manufacturing is fundamental to pharmaceutical production. A single production run produces a defined quantity of product sharing identical manufacturing conditions, raw material sources, and quality test results. Tracking that batch as a unit is therefore a natural extension of how medicines are made.

Serialization goes further by assigning a unique serial number, typically encoded in a 2D barcode or RFID tag, to each individual pack. This allows regulators and supply chain participants to verify the authenticity and history of a single box rather than inferring it from batch membership. The Falsified Medicines Directive in Europe and the Drug Supply Chain Security Act in the United States both mandate serialization for prescription medicines at the unit level.

In practice, the two systems are complementary rather than competing. Serialization data is nested within batch data: a batch contains many serialized units, and a recall or investigation may begin at the batch level before drilling down to individual serial numbers. Pharmaceutical warehouses operating under modern compliance frameworks typically need both, with batch traceability forming the inventory management foundation and serialization providing the unit-level verification layer on top.

What systems and technologies power pharmaceutical batch traceability?

Pharmaceutical batch traceability relies on a combination of warehouse management software, barcode or RFID scanning infrastructure, and, in automated environments, the control systems governing robotic or mechanized storage equipment. No single technology delivers traceability alone; the capability emerges from how these layers are integrated and configured.

Warehouse Management Systems and inventory software

A Warehouse Management System (WMS) is the primary record-keeping layer for batch traceability. It holds the inventory master, maintains location assignments, enforces picking rules such as FEFO, and generates the transaction history that constitutes the audit trail. Pharmaceutical WMS configurations include batch and lot attributes as mandatory fields, meaning no receipt, move, or dispatch transaction can be completed without a valid batch reference.

Where multiple automation technologies operate together, a Warehouse Execution System (WES) or orchestration layer sits above the WMS to coordinate order flow across zones. This layer ensures that batch selection decisions made in the WMS are correctly communicated to each automation system and that the resulting transactions are written back to the central inventory record consistently.

Scanning, labelling, and GS1 standards

Physical identification depends on barcodes, 2D data matrix codes, or RFID tags applied to products and storage locations. GS1 standards define the data structures used in pharmaceutical supply chains, including the Global Trade Item Number (GTIN) for product identification and the Application Identifiers that encode batch number, expiry date, and serial number within a single scannable code. GS1 traceability standards in pharmaceutical logistics are widely referenced by regulators because they provide a common language that works across manufacturers, distributors, and dispensing organizations.

Scanning at each transaction point, whether by a handheld device, a fixed scanner on a conveyor, or a camera integrated into an automated workstation, creates the timestamp and location record that makes the audit trail meaningful. Without reliable scanning discipline, even a well-configured WMS will contain gaps that undermine the traceability chain.

Automated storage and retrieval systems

Automated Storage and Retrieval Systems (AS/RS) contribute to pharmaceutical batch traceability by providing system-controlled inventory locations rather than relying on operators to navigate and select correctly. When the control system directs a retrieval, the batch selected is determined by software logic rather than human judgment, which reduces the risk of picking the wrong lot or bypassing FEFO rules. The control system records the retrieval transaction, and that record integrates with the WMS to maintain the central batch history.

Which regulations require batch traceability in pharmaceutical warehouses?

Batch traceability in pharmaceutical warehouses is required by a range of national and international regulations, with the most significant frameworks being Good Distribution Practice guidelines in Europe, the Drug Supply Chain Security Act in the United States, and equivalent national medicines regulations in most other regulated markets. These frameworks share a common requirement: pharmaceutical supply chain participants must be able to account for the movement and disposition of every batch they handle.

In Europe, the Good Distribution Practice (GDP) guidelines issued under EU Directive 2001/83/EC require wholesale distributors to maintain records that allow the complete traceability of medicinal products. This includes records of receipt, storage conditions, stock movements, and dispatch for every batch. GDP also requires that distributors be able to initiate a recall of any batch within a defined timeframe, which is only possible if traceability records are complete and accessible.

The Falsified Medicines Directive (FMD), implemented through EU Delegated Regulation 2016/161, adds a verification layer for prescription medicines by requiring that each pack be verified against a central repository at the point of dispensing. Wholesale distributors operating within this system must also perform verification at defined points in the supply chain. While FMD operates at the serialized unit level, it relies on the underlying batch infrastructure to function correctly.

In the United States, the Drug Supply Chain Security Act (DSCSA) requires pharmaceutical trading partners to exchange transaction information, transaction history, and transaction statements for each product lot. Wholesale distributors must maintain these records and be able to provide them to the FDA or trading partners upon request.

Beyond these primary frameworks, pharmaceutical warehouses may also be subject to Good Manufacturing Practice (GMP) requirements if they perform secondary packaging or repackaging, national medicines authority regulations, and customer-specific contractual traceability requirements from hospital groups or healthcare purchasing organizations.

How does batch traceability support a pharmaceutical product recall?

Batch traceability makes a pharmaceutical product recall manageable by providing an immediate, queryable record of where every unit from a specific lot was received, stored, and dispatched. When a recall is initiated, the warehouse can run a batch query to identify all stock from the affected lot that remains on-site, all shipments that contained that lot, and all customers or destinations that received product from it. Without this record, locating and containing affected stock requires manual investigation that is slow, incomplete, and unreliable.

The practical recall process typically begins when the warehouse receives a recall notification from the manufacturer or a regulatory authority. The WMS is queried using the batch or lot number as the search key. The system returns a complete disposition report: how much was received, how much remains in stock, and how much was dispatched and to whom. Stock remaining in the warehouse is immediately quarantined, and dispatch records are used to generate customer notifications.

Speed is a critical factor. Regulatory frameworks typically specify timeframes within which a recall must be initiated and affected parties notified. A warehouse with complete, well-structured batch records can generate the necessary information within hours. A warehouse with incomplete or paper-based records may take days to compile the same information, during which affected product may continue to be dispensed to patients.

Traceability records also support the investigation that follows a recall. Quality teams and regulators need to understand not just where the product went but how it was stored, whether temperature conditions were maintained, and whether the batch was handled in accordance with documented procedures. A complete audit trail that includes storage conditions, location history, and transaction timestamps provides the evidence base for that investigation.

What are the most common batch traceability failures in pharma warehousing?

The most common batch traceability failures in pharmaceutical warehouses fall into a small number of recurring categories: incomplete data capture at goods receipt, inconsistent scanning discipline during putaway and picking, system integration gaps that break the audit trail between software platforms, and inadequate enforcement of FEFO or batch-selection rules at the point of pick. Each of these failures creates gaps in the traceability record that become critical during a recall or regulatory inspection.

Incomplete goods receipt data is often the root cause of downstream traceability problems. If a batch number is recorded incorrectly, an expiry date is omitted, or a quantity discrepancy is not resolved at the point of receipt, the error propagates through every subsequent transaction. Corrections made after the fact are harder to validate and create audit trail complexity that regulators scrutinize closely.

Inconsistent scanning during storage and picking is a persistent operational challenge, particularly in manual or semi-automated environments where operators are under throughput pressure. A scan that is skipped, a label that is not read correctly, or a location that is updated in the system without a corresponding physical move all create discrepancies between the system record and the physical reality of the warehouse. These discrepancies are difficult to detect until a stock count or recall exposes them.

System integration gaps arise when batch data does not transfer correctly between platforms. A WMS that records a batch correctly may pass incomplete information to an automation control system, or a dispatch system may generate shipment records that do not carry the batch reference through to the customer-facing documentation. Each interface between systems is a potential point of data loss.

FEFO non-compliance at the point of pick means that the batch selected does not match the batch the system intended to be retrieved. In manual environments this can happen when operators bypass system instructions. In automated environments it can happen when the physical inventory location does not match the system record, causing the automation to retrieve a different lot than intended. Both scenarios result in traceability records that do not accurately reflect what was actually shipped.

Addressing these failures requires a combination of system configuration, process discipline, and regular audit. Traceability is only as reliable as the weakest point in the chain of transactions that builds it.

How Hexxabotics supports batch traceability in pharmaceutical warehousing

Hexxabotics offers a high-density AS/RS solution designed to support the traceability and compliance requirements that pharmaceutical warehousing demands. Because the system provides direct access to every tote without digging or reshuffling, batch selection can be driven entirely by software logic rather than operator judgment, reducing the risk of FEFO non-compliance and incorrect lot retrieval.

Direct tote access: Every storage location is individually retrievable, so the system can act on batch, expiry, or priority instructions without moving surrounding inventory first.
System-controlled retrieval: Robots execute retrieval instructions from the control system, creating a machine-generated transaction record at each step rather than relying on manual scanning discipline.
WMS integration: The Hexxabotics Control System connects to external warehouse management systems through standard APIs, keeping batch records consistent across the software stack.
Goods-to-Person presentation: Totes are brought to operators at workstations where scanning, batch verification, and expiry checking can be performed in a controlled, ergonomic environment.
Scalable architecture: Storage capacity and throughput can be scaled independently, allowing pharmaceutical distributors to grow their assortment or order volume without redesigning the compliance infrastructure around it.

Compliance depends on the complete implementation, including software configuration, validation, operating procedures, and customer processes. Hexxabotics is designed to support batch traceability and regulated pharmaceutical workflows within that broader implementation context. To discuss how the system could be configured for your pharmaceutical distribution or fulfillment operation, contact the Hexxabotics team directly.